Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Piotr Kuna, Marek Jutel, Grazyna Pulka, Slawomir Tokarski, Paula Arranz, Gonzalo Hernández & Nieves Fernández Hernando. (2023) Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study. Clinical Ophthalmology 17, pages 735-746.
Read now
Read now
Articles from other publishers (6)
Eugene B. McLaurin, David Evans, Carolyn S. Repke, Michelle A. Sato, Paul J. Gomes, Erin Reilly, Nysha Blender, Fabiana Q. Silva, Srilatha Vantipalli, Jamie L. Metzinger, Andrea Gibson & Michael H. Goldstein. (2021) Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis. American Journal of Ophthalmology 229, pages 288-300.
Crossref
Crossref
Jonathan Rodrigues, Merin E. Kuruvilla, Kristine Vanijcharoenkarn, Nikki Patel, Milton M. Hom & Dana V. Wallace. (2021) The spectrum of allergic ocular diseases. Annals of Allergy, Asthma & Immunology 126:3, pages 240-254.
Crossref
Crossref
Leonard Bielory. (2020) Allergic inflammation of the anterior surface of the eye. Allergy and Asthma Proceedings 41:6, pages 449-453.
Crossref
Crossref
Nofar Kimchi & Leonard Bielory. (2020) The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Current Opinion in Allergy & Clinical Immunology 20:4, pages 414-420.
Crossref
Crossref
Angelo G. Corsico, Salvatore Leonardi, Amelia Licari, Gianluigi Marseglia, Michele Miraglia del Giudice, Diego G. Peroni, Carmelo Salpietro & Giorgio Ciprandi. (2019) Focus on the cetirizine use in clinical practice: a reappraisal 30 years later. Multidisciplinary Respiratory Medicine 14:1.
Crossref
Crossref
Leonard Bielory & Dovid Schoenberg. (2019) Ocular allergy: update on clinical trials. Current Opinion in Allergy & Clinical Immunology 19:5, pages 495-502.
Crossref
Crossref